Description: (S)-Warfarin is the more active S-enantiomer of warfarin which is used as an anticoagulant in the prevention of thrombosis and thromboembolism, the formation of blood clots in the blood vessels and their migration elsewhere in the body, respectively. It is commonly used to treat blood clots such as deep vein thrombosis and pulmonary embolism and to prevent stroke in people who have atrial fibrillation, valvular heart disease or artificial heart valves. Less commonly it is used following ST-segment elevation myocardial infarction and orthopedic surgery. It is generally taken by mouth but may also be used by injection into a vein. Warfarin was initially introduced in 1948 as a pesticide against rats and mice, and is still used for this purpose, although more potent poisons such as brodifacoum have since been developed. In the early 1950s, warfarin was found to be effective and relatively safe for preventing thrombosis and thromboembolism in many disorders. It was approved for use as a medication in 1954, and has remained popular ever since. Warfarin is the most widely prescribed oral anticoagulant drug in North America.

References: Seecheran R, Seecheran V, Persad S, Seecheran NA. Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus: A Case Report. J Investig Med High Impact Case Rep. 2017 Mar 23;5(1):2324709617697991.

纯度：≥98%

CAS：5543-57-7